PE Ratio
32.13
+0.38+1.20%
Sat, 04 Jan 2025 00:45:06 GMT
Summary:
AstraZeneca price to earnings ratio is currently 32.13, with a rise of +0.38 (+1.20%) during the most recent trading day. Over the past year, it has dropped by -3.62 (-10.13%). AZN PE ratio is now -93.30% below its all-time high of 479.43.AZN PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN PE Ratio Performance
| PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | +1.2% | +1.2% | +0.7% | +4.2% |
| 1 m1 month | -1.6% | -1.6% | - | - |
| 3 m3 months | -14.7% | -14.7% | - | - |
| 6 m6 months | -13.5% | -12.8% | - | - |
| ytdytd | +2.2% | +2.2% | - | - |
| 1 y1 year | -10.1% | -2.1% | +8.9% | +11.8% |
| 5 y5 years | -67.0% | +33.8% | +304.9% | +110.0% |
AZN PE Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 32.83 | -2.1% | 30.71 | +4.6% |
| 3 m | 3 months | 37.65 | -14.7% | 30.41 | +5.7% |
| 6 m | 6 months | 42.51 | -24.4% | 30.41 | +5.7% |
| 1 y | 1 year | 42.51 | -24.4% | 30.41 | +5.7% |
| 3 y | 3 years | 479.43 | -93.3% | 30.41 | +5.7% |
| 5 y | 5 years | 479.43 | -93.3% | 30.41 | +5.7% |
| alltime | all time | 479.43 | -93.3% | 0.29 | >+9999.0% |
AstraZeneca PE Ratio History
| Date | Value |
|---|---|
| 2025 | 32.13(+2.2%) |
| 2024 | 31.44(-10.9%) |
| 2023 | 35.29(-45.1%) |
| 2022 | 64.27(-84.6%) |
| 2021 | 416.07(+915.3%) |
| 2020 | 40.98(-57.7%) |
| 2019 | 96.82(+116.7%) |
| 2018 | 44.68(+52.6%) |
| 2017 | 29.28(+47.8%) |
| 2016 | 19.81(-35.2%) |
| 2015 | 30.59(-57.4%) |
| 2014 | 71.82(+146.8%) |
| 2013 | 29.10(+204.7%) |
| 2012 | 9.55(+50.6%) |
| 2011 | 6.34(-23.7%) |
| 2010 | 8.31(-8.1%) |
| Date | Value |
|---|---|
| 2009 | 9.04(-7.7%) |
| 2008 | 9.79(-14.7%) |
| 2007 | 11.48(-17.5%) |
| 2006 | 13.91(-16.7%) |
| 2005 | 16.70(+2126.7%) |
| 2004 | 0.75(-97.3%) |
| 2003 | 27.33(+27.7%) |
| 2002 | 21.40(-26.6%) |
| 2001 | 29.15(-18.8%) |
| 2000 | 35.91(-44.1%) |
| 1999 | 64.23(+111.8%) |
| 1998 | 30.32(-84.9%) |
| 1997 | 200.45(+1031.8%) |
| 1996 | 17.71(-42.7%) |
| 1995 | 30.89(+113.2%) |
| 1994 | 14.49(-12.6%) |
| 1993 | 16.58 |
FAQ
- What is AstraZeneca price to earnings ratio?
- What is the all time high PE ratio for AstraZeneca?
- What is AZN price to earnings ratio year-to-date change?
- What is AstraZeneca PE ratio year-on-year change?
What is AstraZeneca price to earnings ratio?
The current PE ratio of AZN is 32.13
What is the all time high PE ratio for AstraZeneca?
AstraZeneca all-time high price to earnings ratio is 479.43
What is AZN price to earnings ratio year-to-date change?
AstraZeneca price to earnings ratio has changed by +0.69 (+2.19%) since the beginning of the year
What is AstraZeneca PE ratio year-on-year change?
Over the past year, AZN price to earnings ratio has changed by -3.62 (-10.13%)